PAX3 and neoplasm: This study demonstrates that progression of tumour is delayed in pax3a/pax3b mutant embryos, and that several genes in the RAS/MAPK signalling pathway are down-regulated in the mutants, linking Pax3 transcriptional regulation to one of the main mediators of malignancy in zRMS.